Psoriasis Area and Severity Index (PASI) revisited: A survey on current impression and practice in New Zealand
Sign Up to like & getrecommendations! Published in 2020 at "Australasian Journal of Dermatology"
DOI: 10.1111/ajd.13376
Abstract: papillomavirus in nongenital Bowen’s disease by in situ DNA hybridization. Arch. Dermatol. 1990; 126: 777–81. 4. Svajdler M Jr, Mezencev R, Kaspirkova J et al. Human papillomavirus infection and p16 expression in the immunocompetent patients… read more here.
Keywords: severity index; area severity; index pasi; revisited survey ... See more keywords
The objective Psoriasis Area and Severity Index: a randomized controlled pilot study comparing the effectiveness of ciclosporin and methotrexate
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Dermatology"
DOI: 10.1111/bjd.15350
Abstract: A randomised controlled pilot study was performed to compare the clinical effectiveness of cyclosporine and methotrexate, using a new objective severity assessment method, which we then compared with the Psoriasis Area Severity Index (PASI) for… read more here.
Keywords: controlled pilot; methotrexate; pilot study; severity ... See more keywords
Complete clearance and psoriasis area and severity index response for brodalumab and ustekinumab in AMAGINE‐2 and ‐3
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.16816
Abstract: Modern biologics achieve complete skin clearance [100% improvement in psoriasis area and severity index (PASI 100)] in 30–45% of psoriasis patients. Cumulative benefit considering rapidity, frequency and sustainability of response has not been thoroughly investigated. read more here.
Keywords: severity index; area severity; clearance; psoriasis ... See more keywords
Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort
Sign Up to like & getrecommendations! Published in 2022 at "Acta Dermato-Venereologica"
DOI: 10.2340/actadv.v102.206
Abstract: Real-world evidence, directly comparing the effectiveness of interleukin (IL)17-inhibitors, IL23-inhibitors, tumour necrosis factor alpha (TNF-α)-inhibitors and an IL12/23-inhibitor in psoriasis, is scarce. The aim of this study was to directly compare the first-year effectiveness of… read more here.
Keywords: psoriasis area; multicentre cohort; psoriasis; real world ... See more keywords